Detection of hepatitis C virus (HCV) RNA by PCR among hemodialysis patients attending a tertiary care centre, Mysuru, South India

R. D Nivedita; A Tejashree; M Krishna Karthik; B Satya Sai; Prasanna Kumar; Eeshita Dhar

doi:10.53730/ijhs.v6nS2.5567

Authors

Nivedita R. D MSc Postgraduate, Dept of Microbiology, JSSMC, JSSAHER, Mysore
A Tejashree Prof & HOD, Dept of Microbiology, JSSMC, JSSAHER, Mysore
Krishna Karthik. M
krishnakarthik46@gmail.com
Tutor and Research Scholar, Dept of Microbiology, JSSMC, JSSAHER, Mysore
Satya Sai. B Tutor and Research Scholar, Dept of Microbiology, JSSMC, JSSAHER, Mysore
Prasanna Kumar Research Scholar, Dept of Microbiology, JSSMC, JSSAHER, Mysore
Eeshita Dhar Research Scholar, Dept of Microbiology, JSSMC, JSSAHER, Mysore

Keywords:

HCV infection, hemodialysis, PCR

Abstract

The infection rate of Hepatitis C virus in chronic hemodialysis (HD) patients is comparitively higher than the normal population. Hepatocellular carcinoma and cirrhosis are the major complications that have been frequently reported among the patients with HCV infection who were on hemodialysis. Hence, continuous monitoring of HCV infection in hemodialysis settings at health care centres may aim towards the assessment and prevention of device induced infection. Hence this current study was aimed to detect the HCV RNA using PCR among hemodialysis patients attending JSS, a tertiary care centre situated in Mysuru, South India.

Downloads

Download data is not yet available.

References

Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to ccirrhosis and primary liver cancer worldwide. J Hepatol2006;45:529‑38.

Attaullah S, Ali I, Ayaz S, et al. Rising burden of Hepatitis C Virus in hemodialysis patients. Virol J. 2011;8:438.

Fabrizi F, Dixit V, Messa P, Martin P. Hepatitis C-related liverdisease in dialysis patients. Hepatitis C in renal disease,hemodialysis and transplantation. ContribNephrol.2012;176:42e53.

Puri Pankaj, Anand Anil C, SaraswatVivek A, et al. Consensusstatement of HCV task force of the Indian NationalAssociation for Study of the Liver (INASL). Part I: status reportof HCV infection in India. ClinExpHepatol. 2014Jun;4(2):106e116.

Schneeberger PM, Keur I, van Loon AM, et al. The prevalenceand incidence of hepatitis C virus infections among dialysispatients in The Netherlands: a nationwide prospective study.J Infect Dis. 2000 Nov;182(5):1291e1299.

Duong CM, McLaws ML. An investigation of an outbreak of hepatitisC virus infections in a low-resourcedhemodialysis unit inVietnam. Am J Infect Control. 2016;44(5):560‐566.

Chang J-M, Huang C-F, Chen S-C, et al. Discrepancy between serological and virological analysis of viral hepatitis in hemodialysis patients. Int J Med Sci. 2014;11(5):436‐441.

Li Cavoli G, Zagarrigo C, Schillaci O, et al. Hepatitis C virus core antigen test in monitoring of dialysis patients. Hepat Res Treat. 2012;2012:4.

Gupta E, Bajpai M, Choudhary A. Hepatitis C virus: screening, diagnosis, and interpretation of laboratory assays. Asian J Transfusion Sci. 2014;8(1):19‐25.

Vidales-Braz BM, da Silva NMO, Lobato R, et al. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients. Virol J. 2015;12(1):8.

Chang J-M, Huang C-F, Chen S-C, et al. Discrepancy between serological and virological analysis of viral hepatitis in hemodialysis patients. Int J Med Sci. 2014;11(5):436‐441.

Fletcher GJ, Raghavendran A, Sivakumar J, Samuel P, Abraham P.Diagnostic reliability of Architect anti-HCVassay: experience of a tertiary care hospital in India. J Clin Lab Anal. 2018;32:e22245.

Col Partha Roy, (Retd) , Anubha Patel , Kavita Lole ,Maj Gen R.M. Gupta, VSM, Col Arun Kumar , S. Hazra. Prevalence and genotyping pattern of hepatitis C virus among patients on maintenance hemodialysis at five centers in Pune, India: Science direct Elsevier, Medical journal armed forces India; 75, 2019, 74-80.

L. Finelli, J. T. Miller, J. I. Tokars, M. J. Alter, and M. J. Arduino, “National surveillance of dialysis-associated diseases in the United States, 2002,” Seminars in Dialysis, vol. 18, no. 1, pp. 52–61, 2005.

R. S. Ross, S. Viazov, R. Clauberg et al., “Lack of de novo hepatitis C virus infections and absence of nosocomial transmissions of GB virus C in a large cohort of German haemodialysis patients,” Journal of Viral Hepatitis, vol. 16, no. 4, pp. 230–238, 2009.

S. Nakai, K. Suzuki, I. Masakane et al., “Overview of regular dialysis treatment in Japan (as of 31 December 2008),” Therapeutic Apheresis and Dialysis, vol. 14, no. 6, pp. 505–540, 2010

Poovorawan Y, Chatchatee P, Chongsrisawat V. Epidemiology and prophylaxis of viral hepatitis: a global perspective. J Gastroenterol Hepatol. 2002;17:155–66.

Maryam Moini , Mazyar Ziyaeyan et al; Hepatitis C virus (HCV) Infection Rate among Seronegative Hemodialysis Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction: Hepat Mon. 2013;13(6):e9147

Atieh Makhlough,1 Mohammadreza Mahdavi et a ; The Prevalence of HCV Infection in Hemodialysis Population and Compared ELISA and PCR Methods for Detecting of HCV Infection: Nephrourol Mon. 2017; 9(3):e45144.

Atieh Makhlough,1 Mohammadreza Mahdavi et al: The Prevalence of HCV Infection in Hemodialysis Population and Compared ELISA and PCR Methods for Detecting of HCV Infection; Nephrourol Mon. 2017; 9(3):e45144.

Radka T. Komitova, Maria V. Atanasova et al: Diagnostic Dilemmas in Hepatitis C Virus Infection for Hemodialysis Patients; Folia Medica I 2017 I Vol. 59 I No. 1.